| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Invega Sustenna 25 mg modified release injection, syringe |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
| Lucrin Depot 3-Month (leuprorelin acetate 22.5 mg) modified release injection, 22.5 mg syringe |
has manufactured dose form |
False |
modified release injection |
Inferred relationship |
Some |
|
| Somatuline LA (lanreotide 30 mg) modified release injection, 30 mg vial |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
| Eligard 4 Month (leuprorelin acetate 30 mg) modified release injection, 30 mg syringe |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
| Eligard 1 Month (leuprorelin acetate 7.5 mg) modified release injection, 7.5 mg syringe |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
| Zyprexa Relprevv (olanzapine 300 mg) modified release injection, 300 mg vial |
has manufactured dose form |
False |
modified release injection |
Inferred relationship |
Some |
|
| Zyprexa Relprevv (olanzapine 210 mg) modified release injection, 210 mg vial |
has manufactured dose form |
False |
modified release injection |
Inferred relationship |
Some |
|
| Eligard 3 Month (leuprorelin acetate 22.5 mg) modified release injection, 22.5 mg syringe |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
| Risperdal Consta (risperidone 50 mg) modified release injection, 50 mg vial |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
| Lucrin Depot (leuprorelin acetate 7.5 mg) modified release injection, 7.5 mg syringe |
has manufactured dose form |
False |
modified release injection |
Inferred relationship |
Some |
|
| Invega Sustenna 75 mg modified release injection, syringe |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
| Zyprexa Relprevv (olanzapine 405 mg) modified release injection, 405 mg vial |
has manufactured dose form |
False |
modified release injection |
Inferred relationship |
Some |
|
| Sandostatin LAR (octreotide 30 mg) modified release injection, 30 mg vial |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
| Abilify Maintena (aripiprazole 400 mg) modified release injection, 400 mg vial |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
| aripiprazole 400 mg modified release injection, vial |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
| aripiprazole 300 mg modified release injection, vial |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
| Abilify Maintena (aripiprazole 300 mg) modified release injection, 300 mg vial |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
| Lucrin Depot Paediatric (leuprorelin acetate 30 mg) modified release injection, 30 mg syringe |
has manufactured dose form |
False |
modified release injection |
Inferred relationship |
Some |
|
| testosterone undecanoate 1 g/4 mL modified release injection, ampoule |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
| Reandron-1000 1 g/4 mL modified release injection, 4 mL ampoule |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
| Reandron-1000 1 g/4 mL modified release injection, 4 mL vial |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
| testosterone undecanoate 1 g/4 mL modified release injection, vial |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
| Lucrin Depot 6-Month (leuprorelin acetate 45 mg) modified release injection, 45 mg syringe |
has manufactured dose form |
False |
modified release injection |
Inferred relationship |
Some |
|
| leuprorelin acetate 45 mg modified release injection, syringe |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
| Eligard 6 Month (leuprorelin acetate 45 mg) modified release injection, 45 mg syringe |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
| pasireotide 20 mg modified release injection, vial |
has manufactured dose form |
False |
modified release injection |
Inferred relationship |
Some |
|
| Signifor LAR (pasireotide 20 mg) modified release injection, 20 mg vial |
has manufactured dose form |
False |
modified release injection |
Inferred relationship |
Some |
|
| Signifor LAR (pasireotide 40 mg) modified release injection, 40 mg vial |
has manufactured dose form |
False |
modified release injection |
Inferred relationship |
Some |
|
| pasireotide 40 mg modified release injection, vial |
has manufactured dose form |
False |
modified release injection |
Inferred relationship |
Some |
|
| Signifor LAR (pasireotide 60 mg) modified release injection, 60 mg vial |
has manufactured dose form |
False |
modified release injection |
Inferred relationship |
Some |
|
| pasireotide 60 mg modified release injection, vial |
has manufactured dose form |
False |
modified release injection |
Inferred relationship |
Some |
|
| Bydureon (exenatide 2 mg) modified release injection, 2 mg cartridge |
has manufactured dose form |
False |
modified release injection |
Inferred relationship |
Some |
|
| exenatide 2 mg modified release injection, cartridge |
has manufactured dose form |
False |
modified release injection |
Inferred relationship |
Some |
|
| exenatide 2 mg/dose + inert substance modified release injection, dose |
has manufactured dose form |
False |
modified release injection |
Inferred relationship |
Some |
|
| Bydureon (exenatide 2 mg/dose + inert substance) modified release injection, dose |
has manufactured dose form |
False |
modified release injection |
Inferred relationship |
Some |
|
| exenatide 2 mg modified release injection, vial |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
| Bydureon (exenatide 2 mg) modified release injection, 2 mg vial |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
| Trevicta 175 mg/0.875 mL modified release injection, 0.875 mL syringe |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
| paliperidone 175 mg/0.875 mL modified release injection, syringe |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
| paliperidone 263 mg/1.315 mL modified release injection, syringe |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
| Invega Trinza 263 mg/1.315 mL modified release injection, 1.315 mL syringe |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
| Trevicta 263 mg/1.315 mL modified release injection, 1.315 mL syringe |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
| paliperidone 525 mg/2.625 mL modified release injection, syringe |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
| Invega Trinza 350 mg/1.75 mL modified release injection, 1.75 mL syringe |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
| paliperidone 350 mg/1.75 mL modified release injection, syringe |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
| Trevicta 350 mg/1.75 mL modified release injection, 1.75 mL syringe |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
| Invega Trinza 525 mg/2.625 mL modified release injection, 2.625 mL syringe |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
| Invega Trinza 175 mg/0.875 mL modified release injection, 0.875 mL syringe |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
| Trevicta 525 mg/2.625 mL modified release injection, 2.625 mL syringe |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
| Depocyt 50 mg/5 mL modified release injection, 5 mL vial |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
| cytarabine 50 mg/5 mL modified release injection, vial |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
| Lucrin Depot (leuprorelin acetate 3.75 mg) modified release injection, 3.75 mg vial |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
| leuprorelin acetate 3.75 mg modified release injection, vial |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|